How to Buy Geron Stock
Geron Corp
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies.
Geron stock last closed at $4.15, down 3.94% from the previous day, and has increased 129.28% in one year. It has overperformed other stocks in the Biotechnology industry by 1.42 percentage points. Geron stock is currently +153.05% from its 52-week low of $1.64, and -22.28% from its 52-week high of $5.34.
At the moment, there are 602.8M GERN shares outstanding. The market cap of GERN is $2.50B. In the past 24 hours, 7.63M GERN shares were traded.
How to Buy Geron Stock
Not sure how to invest in Geron stock? Here's how.
- Choose where to buy Geron stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Geron stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Select your method of payment and add your details.
- Evaluate Geron stock: The Geron ticker symbol is GERN. Is Geron stock a good investment? Should you buy shares of GERN? How do GERN's underlying business fundamentals look? Do top analysts think Geron is a good buy? Why has GERN's stock price moved recently? (Hint: Our stock research tools can help you decide if GERN is a good stock to buy).
- Place your GERN trade: Decide if you will purchase GERN shares at the current market price or use a limit order to purchase GERN shares at a particular price.
- Get the latest scoop on your investment in GERN: Create a watchlist to keep tabs on your investment in Geron shares.
Step 1: Choose where to buy Geron stock
You need a brokerage account to access the NASDAQ market and buy GERN shares.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Technology to Healthcare, New York to London — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro today.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal info so you can invest in GERN stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to start a new trading account.
- Submit your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have finished signing up on the best stock investing app, you can securely and quickly fund your account:
Check out this video walkthrough if you need help transferring money into your brokerage account.
Step 4: Evaluate Geron stock
Once you have chosen the best place to buy Geron stock, it's crucial to analyze their stock prior to investing, so you actually comprehend the risk and opportunity.
Geron stock quick numbers
Geron Fundamentals
WallStreetZen was created to help part-time investors do more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on GERN's stock page.
Is GERN stock overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge GERN's intrinsic value.
Using relative valuations metrics:
- GERN could be overvalued based on its P/B ratio of 8.16x, relative to Biotechnology industry P/B ratio of 5.95x
You can do more valuation analysis on GERN's stock here.
How do GERN Financials look?
Signs that GERN is financially healthy:
- There are more short-term assets than long-term liabilities on the GERN balance sheet.
- GERN has cash burn of 208585000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the GERN balance sheet.
Signs that GERN is not financially healthy:
- Total GERN debt is higher than 5 years ago, relative to shareholder equity.
- GERN profit margin has gone up by 220.17 percentage points in the past year, but the company is still unprofitable.
- GERN has $363.86M in cash and short term investments. This is not sufficient to cover its annual cash burn of $208.59M.
- GERN has a relatively high debt to equity ratio of 0.47.
Is GERN stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 7 sell side analysts who monitor GERN, the consensus analyst rating on GERN is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent GERN Analyst Upgrades/Downgrades
Robert Driscoll, a top 4% analyst from Wedbush reiterates GERN with a buy rating and maintains their GERN price target from $7.00 to $7.00, on Jun 7, 2024.
Joel Beatty, a top 26% analyst from Baird downgrades GERN to a hold rating and maintains their GERN price target from $4.50 to $4.50, on Apr 30, 2024.
Tara Bancroft, a top 45% analyst from TD Cowen initiates coverage on GERN with a strong buy rating and announces their GERN price target of $10.00, on Apr 29, 2024.
You can dive deeper into what analysts are projecting on the Geron stock forecast page.
GERN Momentum
GERN Earnings
Last year, GERN revenue was $1.37M. In the past 5 year, GERN's revenue has increased by 14.49% per year. This was slower than the Biotechnology industry average of 59.82%.
Dig into GERN's earnings and revenue performance here.
What are GERN executives and large shareholders up to?
In the past 12 months, executives and large shareholders at GERN have bought as many shares as they have sold.
Andrew J. Grethlein, EVP Chief Operating Officer of GERN, was the latest GERN insider to sell. They sold $3,073,003.84 worth of GERN stock on Jul 8, 2024.
Research more about who owns GERN shares here.
Does GERN stock generate passive income?
No, Geron doesn't provide an income stream by paying out dividends.
GERN Social Trading Data
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your GERN trade
You have two main order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular price limit, place a limit order.
Click the Open Trade button and your broker will place the order.
If you need additional help with investing in stocks on eToro, watch the helpful video below:
Step 6: Get the latest scoop on your investment in GERN
Now that you own some shares in GERN, you'll want to stay up-to-date on your new shares.
Start a watchlist to get notified of the latest news about your GERN stock.
GERN Feed
How to Buy Stock in Geron
To reiterate, here are the 6 steps for buying Geron stock:
- Choose where to buy Geron stock
- Sign up for a brokerage account
- Deposit funds into your investment account
- Evaluate Geron stock
- Place your GERN trade
- Get the latest scoop on your investment in GERN
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Geron, get started below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.